News
-
-
-
China’s First Trastuzumab Biosimilar 汉曲优® Approved by NMPA
2020-08-14
-
-
-
-
Fosun International improves MSCI ESG rating to grade A
2020-08-13
Fosun International’s MSCI ESG rating has improved from BBB last year to A in 2020.
-
-
-
-
Peak Re named “Asian Reinsurer of the Year” for the fifth consecutive time
2020-08-07
-
-
-
-
Wolves brand named in football's top 20
2020-08-07
-
-
-
-
Challenge Dilemmas in The Treatment of SCCHN, Henlius Innovative Combination Therapy Dosed The First Patient in A Phase 2 Clinical Trial
2020-07-30
-
-
-
-
Guo Guangchang: The First Dose! The novel coronavirus mRNA vaccine has officially started the human clinical trial in China
2020-07-29
-
-
-
-
Fidelidade Macau Insurance Company donates 5,000 face masks to Caritas Macau
2020-07-23
-
-
-
-
Nuno wins Manager of the Month award | 10th July 2020
2020-07-21
-
-
-
-
Fosun Pharma Announces its Licensed COVID-19 Vaccine Product Receives Acceptance Notice of Clinical Trial Application by NMPA
2020-07-14
-
